Why BGPT?
logo

Review Papers Against Their Own Results

Check whether claims match experiments, exact reported results, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review paper


     Quick Explanation



    This 2019 Epigenetics & Chromatin study integrates ATAC-seq, p63/CTCF ChIP-seq, RNA-seq and published promoter-capture Hi-C in EEC patient keratinocytes, showing p63 mutation reduces chromatin accessibility at p63- and CTCF-bound open regions while CTCF binding itself remains stable, supporting a model where p63 cooperates non-covalently with CTCF at promoter-enhancer loops regulating epidermal genes.


     Long Explanation



    Core findings and supporting evidence

    The authors performed ATAC-seq on primary human keratinocytes from EEC syndrome patients carrying p63 DNA-binding-domain mutations (R204W, R304W) plus one control donor. They identified 2,492 control-specific open chromatin regions (Ctr-OCRs) and 3,716 mutant-specific OCRs, with differential OCRs correlating positively with nearby differential gene expression (cell-cycle genes near Ctr-OCRs; actin filament-based processes near Mt-OCRs) .

    Motif analysis revealed p63 as the most enriched motif in Ctr-OCRs, with CTCF unexpectedly second. Critically, at the 376 CTCF-bound Ctr-OCRs, ATAC signal dropped in mutants but CTCF ChIP-seq signal was unchanged (only 363 of 12,116 CTCF sites were differential), whereas p63 binding clearly decreased at its 1,223-bound Ctr-OCRs. Overlap between p63 and CTCF binding sites was minimal (~435 of 45,350 vs 12,116 sites), arguing against direct protein-protein co-occupancy .

    Looping model and gene regulation

    Integrating published keratinocyte promoter-capture Hi-C, the authors mapped 388 p63-bound and 191 CTCF-bound Ctr-OCRs to loop anchors, and found 96 genes significantly co-connected by both (p < 0.001); 39 of these were deregulated in mutants, including KRT5 and KRT75. In 70.6% of same-loop cases both factors sat at the promoter, and in 12.6% p63 and CTCF occupied opposite anchors .

    The "inactive loop" interpretation β€” that CTCF maintains static loop structure while p63 supplies the cell-type-specific transcriptional activity β€” fits the unchanged CTCF ChIP signal and is broadly consistent with later mechanistic work showing CTCF N-terminus–cohesin interactions stabilize CTCF-anchored loops (2,756 WT vs ~98 mutant loops upon CTCF Y226A/F228A mutation) and that promoter-bound CTCF can have position-dependent non-architectural transcriptional roles .

    Critical assessment and blind spots

    • Sample size and confounding: Only one control donor (Dombi23) versus two patient lines; donor-level variation cannot be separated from genotype effects, and the authors pooled the two mutants to mitigate this .
    • No direct 3D perturbation: The study used published PCHi-C rather than performing Hi-C in mutant keratinocytes; the claim that loops are "static but inactive" is inferred, not measured. The authors themselves propose HiChIP/ChIA-PET as follow-up.
    • Correlation vs causation: Only 39/96 co-connected genes were deregulated; the authors invoke "shadow enhancers" as one explanation but do not test it. No CRISPR deletion of individual p63 or CTCF motifs was performed to prove loop-level causality.
    • Observational stability of CTCF: The unchanged CTCF ChIP signal could partly reflect antibody sensitivity limits rather than true constancy, a nuance not quantified.
    • Scope: Findings are keratinocyte-specific; generality of TF–CTCF cooperation across cell types is supported by later reviews and perturbation studies but remains context-dependent .

    What would falsify the model: CTCF ChIP-seq performed acutely after p63 loss showing broad binding loss, or loop resolution 3C/HiChIP demonstrating unchanged loop structure and activity across all 96 genes, would undermine the proposed two-tier (static CTCF, dynamic p63) architecture. Conversely, restoring wild-type p63 in patient keratinocytes should rescue accessibility at Ctr-OCRs β€” a rescue experiment not yet reported.

    Confidence and caveats

    Confidence in the reported ATAC/ChIP observations is moderate-high (well-validated workflows, DESeq2/MACS2/HOMER/CHiCAGO pipelines, public data at GSE123711); confidence in the mechanistic cooperation model is moderate because it rests on correlative integration rather than direct perturbation of loops.



    Feedback:    

    Updated: October 26, 2026

     BGPT Paper Review



    Study Novelty

    70%

    First line of evidence that a lineage-specific TF (p63) cooperates with CTCF in promoter-enhancer looping in keratinocytes; built on the same group's 2018 enhancer-rewiring work, so incremental rather than paradigm-shifting, but the CTCF finding was genuinely unexpected.



    Scientific Quality

    70%

    Solid multi-omics integration with reproducible replicates and public data (GSE123711); weakened by a single control donor, reliance on published Hi-C rather than mutant Hi-C, no causal perturbation of loops, and interpretive leaps about static loops without direct measurement.



    Study Generality

    60%


    Study Usefulness

    70%


    Study Reproducibility

    70%

    ATAC/ChIP pipelines (BWA, MACS2, DESeq2, HOMER, CHiCAGO) are standard and data deposited at GEO GSE123711, but in-house code available only 'on request' and the single control donor limits independent replication of group comparisons.



    Explanatory Depth

    60%

    Provides a coherent two-tier model (static CTCF loops, p63-dependent activity) but leaves causality untested; 57/96 co-regulated genes not deregulated remain unexplained beyond a shadow-enhancer conjecture.


    🎁 Authors: Collect 172 Free Science Tokens (β‰ˆ $17.2 USD)

    Claim My Author Tokens

    Use for 43 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $17.2 USD)

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    p63 and CTCF cooperate through direct protein-protein interaction at shared binding sites β€” rejected by the authors' own data showing only ~435 overlapping sites of 45,350 p63 and 12,116 CTCF BSs and no visible reciprocal ChIP signal.


    The differential accessibility at Ctr-OCRs is a direct consequence of CTCF loss β€” rejected because CTCF ChIP signals at the 376 CTCF-bound Ctr-OCRs were unchanged in mutants, indicating CTCF occupancy itself is not the p63-dependent variable.

     Science Art


    Paper Review: p63 cooperates with CTCF to modulate chromatin architecture in skin keratinocytes Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT